BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng QC, Fan J, Deng XW, Liu HC, Ding HR, Fang X, Wang JW, Chen CH, Zhang WG. Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis. World J Gastroenterol 2020; 26(41): 6346-6360 [PMID: 33244197 DOI: 10.3748/wjg.v26.i41.6346] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Sun Y, Liu S, Yang S, Chen C, Yang Y, Lin M, Liu C, Wang W, Zhou X, Ai Q, Wang W, Chen N. Mechanism of Dihydromyricetin on Inflammatory Diseases. Front Pharmacol 2022;12:794563. [DOI: 10.3389/fphar.2021.794563] [Reference Citation Analysis]
2 Chen J, Wang X, Xia T, Bi Y, Liu B, Fu J, Zhu R. Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease. Biomed Pharmacother 2021;142:111927. [PMID: 34339914 DOI: 10.1016/j.biopha.2021.111927] [Reference Citation Analysis]